"XBB" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonNeutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-co...
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among a...
Bivalent mRNA vaccine booster enhances Immunity against XBB.1.5 more effectively than breakthroug...
Bivalent mRNA vaccine booster enhances Immunity against XBB.1.5 more effectively than breakthrough infection in K18-hACE2 mice ScienceDirect.com
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduce...
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell ...
Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-r...
Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimat...
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-1...
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 su...
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection Nature
Neutralizing antibody responses to three XBB protein vaccines in older adults - Nature
Neutralizing antibody responses to three XBB protein vaccines in older adults Nature
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strai...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines Nature
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant Nature
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity - Nature
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity Nature
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System Nature
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 Nature
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage...
COVID-19 NB.1.8.1 variant 2025: Symptoms, How to treat - MedPark Hospital
COVID-19 NB.1.8.1 variant 2025: Symptoms, How to treat MedPark Hospital
Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine booste...
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to...
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids CIDRAP
S. Korean health authorities reject baseless 'Omicron surge' warning - AFP Fact Check
S. Korean health authorities reject baseless 'Omicron surge' warning AFP Fact Check
XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight - Seeking Alpha
XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight Seeking Alpha
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduce...
Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 w...
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vacci...
Updated BNT162b2 XBB COVID-19 Vaccine Protects Against Hospitalization in Children Aged 5 to 17 -...
Updated BNT162b2 XBB COVID-19 Vaccine Protects Against Hospitalization in Children Aged 5 to 17 Pharmacy Times
Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, Octobe...
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmis...
Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...
Genomic Surveillance for SARS-CoV-2 Variants: ... Centers for Disease Control and Prevention | CDC (.gov)
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke School of Medicine
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design Duke School of Medicine
TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)
TAG-VE statement on Omicron sublineages BQ.1 and XBB World Health Organization (WHO)
The potential impact of the spreading of highly transmissible Omicron variant XBB.1.5 and JN.1 on...
What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...
What You Need to Know About XBB.1.5, the Latest Omicron Variant Johns Hopkins Bloomberg School of Public Health
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...
Full article: Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deat...
Full article: Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study Taylor & Francis Online
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the abse...
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XB...
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada:...
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - Centers for Disease Control and P...
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... Centers for Disease Control and Prevention | CDC (.gov)
CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News - American Ho...
CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News American Hospital Association
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recogn...
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition ScienceDirect.com
Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine
Durability of XBB.1.5 Vaccines against Omicron Subvariants The New England Journal of Medicine
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB The New England Journal of Medicine
Here’s what we know about the new Omicron variant XBB.1.5 - Gavi, the Vaccine Alliance
Here’s what we know about the new Omicron variant XBB.1.5 Gavi, the Vaccine Alliance
Coronavirus variant XBB.1.5 rises in the United States — is it a global threat? - Nature
Coronavirus variant XBB.1.5 rises in the United States — is it a global threat? Nature
Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice - Frontiers
Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice Frontiers
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variant...
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants ScienceDirect.com
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant PBS
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - The New England Jo...
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster The New England Journal of Medicine
Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network
Rising cases of COVID-19 variant, XBB.1.5 Mayo Clinic News Network
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in h...
Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans ScienceDirect.com
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 The New England Journal of Medicine
XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video | AMA -...
XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video | AMA ama-assn.org
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant Nature
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know Yale Medicine
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...
The Updated COVID Vaccines Are Here: 9 Things to Know - Yale Medicine
The Updated COVID Vaccines Are Here: 9 Things to Know Yale Medicine
WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries - CIDRAP
WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries CIDRAP
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
The rise of variant XBB.1.5, and more — this week’s best science graphics - Nature
The rise of variant XBB.1.5, and more — this week’s best science graphics Nature
XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant - UC Davis
XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant UC Davis
US COVID markers continue upward trend as newer XBB variant proportions grow - CIDRAP
US COVID markers continue upward trend as newer XBB variant proportions grow CIDRAP
The XBB.1.5 variant is taking over on the East Coast. Will it happen in California too? - Los Ang...
The XBB.1.5 variant is taking over on the East Coast. Will it happen in California too? Los Angeles Times
As fake news spread that a new deadly COVID-19 variant "XBB" recently came out, the quarantine au...
Continued evasion of neutralizing antibody response by Omicron XBB.1.16 - ScienceDirect.com
Continued evasion of neutralizing antibody response by Omicron XBB.1.16 ScienceDirect.com
Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countri...
Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 ...
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID...
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster ScienceDirect.com
WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency - CIDRAP
WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency CIDRAP
SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts - News24
SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts News24
The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of...
Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...
XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP
XBB booster offers protection against JN.1 infections, hospital cases, new data show CIDRAP
Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 ...
Pfizer-BioNTech XBB COVID-19 Vaccine Demonstrates 62% Protection Against Hospitalization - Contag...
Pfizer-BioNTech XBB COVID-19 Vaccine Demonstrates 62% Protection Against Hospitalization Contagion Live
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” Gavi, the Vaccine Alliance
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know American Society for Microbiology
XBB.1.5 subvariant: CDC reports new omicron strain taking over - NBC News
XBB.1.5 subvariant: CDC reports new omicron strain taking over NBC News
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall - CNBC
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall CNBC
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB ...
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB ScienceDirect.com
What Is XBB? New Infectious Omicron Variant, COVID - Business Insider
What Is XBB? New Infectious Omicron Variant, COVID Business Insider
Covid variant 'Arcturus' is spreading: What to know about XBB.1.16 - NBC News
Covid variant 'Arcturus' is spreading: What to know about XBB.1.16 NBC News
Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5 - News-Medical
Bivalent boosters provide additional protection from BA.5, XBB, and XBB.1.5 News-Medical
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infecti...
How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst ex...
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths - CIDRAP
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths CIDRAP
Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American
Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious Scientific American
Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from prev...
Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...
Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine bo...
Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster ScienceDirect.com